Cataflam — Class III drug recall D-1516-2014
Terminated recall by Novartis Pharmaceuticals Corp., reported 2014-08-13, distributed nationwide. Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegib
| Recall number | D-1516-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Novartis Pharmaceuticals Corp., Suffern, NY, United States |
| Recall initiated | 2014-07-30 |
| Classified | 2014-08-06 |
| Reported by FDA | 2014-08-13 |
| Terminated | 2014-12-05 |
| Distributed | Nationwide (US) |
| Quantity | 50 bottles |
| NDC | 00078-0436-05 |
Product
Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.
Reason for recall
Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1516-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.